Research on Innovative Diagnosis and Treatment System of Syndrome Differentiation of Zang-fu Viscera and Effectiveness Evaluation Based on Inter-Arm Blood Pressure Measured Simultaneously
1 other identifier
observational
750
1 country
1
Brief Summary
By combining the measurement of blood pressure in both arms with the information of the four diagnoses of TCM, we try to form a diagnostic model of "five diagnoses combined with ginseng" based on TCM Zang-fu syndrome differentiation. It can further objectify and visualize the fuzzy four diagnostic indicators of TCM. In order to solve the problem of data differentiation of TCM four diagnoses, and optimize the five diagnoses of TCM conjunctive index, explore the establishment of TCM intelligent diagnosis and treatment and contact evaluation computer system
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2022
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2022
CompletedFirst Submitted
Initial submission to the registry
December 10, 2022
CompletedFirst Posted
Study publicly available on registry
December 28, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedDecember 28, 2022
December 1, 2022
3 years
December 10, 2022
December 18, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Blood pressure measurement in both arms
The systolic blood pressure, diastolic blood pressure and pulse rate of the left and right upper arms were simultaneously measured by a standard dual-arm electronic sphygmomanometer. A total of 6 data were collected. A total of 30 data were collected and measured for 5 times without interruption, which was used to judge the functional balance state of "Zang-fu regional tissues" in human body.
5minutes
Secondary Outcomes (6)
Pulse diagnosis information
10minutes
Pittsburgh Sleep Quality Index (PSQI)
5minutes
Hamilton Anxiety Scale (HAMA)
5minutes
Hamilton Depression Scale (HAMD)
5minutes
Gastrointestinal Symptom Scale
5minutes
- +1 more secondary outcomes
Study Arms (3)
Healthy people
The physical examination ruled out the disease
Chronic gastritis
The endoscopic diagnosis is consistent with chronic gastritis or self-reported stomachache
Insomnia
The Pittsburgh Sleep Quality Index Scale was measured and assessed as meeting a diagnosis of insomnia disorder or self-reported insomnia for more than three months
Eligibility Criteria
Physical examination center and Hospital Outpatient Clinic
You may qualify if:
- Patients were treated with epigastric pain and / or insomnia, which met the above diagnostic criteria for diseases, liver and spleen;
- diagnostic criteria for diseases, liver and spleen;
- Age 18-65 years old;
- It can combine mild and moderate depression, anxiety Sign the informed consent form.
- PSQI \< 5 points;
- No hypertension, diabetes, hyperlipidemia, coronary heart disease and other underlying diseases;
- No depression, anxiety, malignant tumor, syphilis, HIV and other infectious diseases;
- Over 18 years of age;
- Volunteer to participate in this study, cooperate with the measurement of blood pressure in both arms, and sign the informed consent.
You may not qualify if:
- Patients with insomnia disorder caused by uneffectively controlled or serious diseases, such as malignant tumor, persistent pain, cardiovascular and cerebrovascular diseases, endocrine diseases, etc.;
- patients with severe depression and mental illness;
- Pregnant and lactation patients.
- sleep apnea syndrome or restless leg syndrome and other sleep disorders;
- Pregnant and lactation;
- Abnormal symptoms and abnormal tongue pulse occur in the body, such as facial acne, dysmenorrhea, thick and greasy tongue coating, loose stools, fat tongue, teeth marks and tongue.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Liyun Helead
- Beijing University of Chinese Medicinecollaborator
- Beijing Shijitan Hospital, Capital Medical Universitycollaborator
- Affiliated Hospital of Inner Mongolia Minzu Universitycollaborator
- Hohhot Hospital of Mongolian Medicine and TCMcollaborator
Study Sites (1)
Beijing Shijitan Hospital, Capital Medical University
Beijing, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Director of TCM Clinical Efficacy Evaluation Center
Study Record Dates
First Submitted
December 10, 2022
First Posted
December 28, 2022
Study Start
January 1, 2022
Primary Completion
December 31, 2024
Study Completion
December 31, 2024
Last Updated
December 28, 2022
Record last verified: 2022-12
Data Sharing
- IPD Sharing
- Will not share